A Mechanism of O-Demethylation of Aristolochic Acid I by Cytochromes P450 and Their Contributions to This Reaction in Human and Rat Livers: Experimental and Theoretical Approaches

. 2015 Nov 18 ; 16 (11) : 27561-75. [epub] 20151118

Jazyk angličtina Země Švýcarsko Médium electronic

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid26593908

Grantová podpora
14329 Cancer Research UK - United Kingdom
C313/A14329 Cancer Research UK - United Kingdom

Odkazy
PubMed 26593908
PubMed Central PMC4661905
DOI 10.3390/ijms161126047
PII: ijms161126047
Knihovny.cz E-zdroje

Aristolochic acid I (AAI) is a plant alkaloid causing aristolochic acid nephropathy, Balkan endemic nephropathy and their associated urothelial malignancies. AAI is detoxified by cytochrome P450 (CYP)-mediated O-demethylation to 8-hydroxyaristolochic acid I (aristolochic acid Ia, AAIa). We previously investigated the efficiencies of human and rat CYPs in the presence of two other components of the mixed-functions-oxidase system, NADPH:CYP oxidoreductase and cytochrome b₅, to oxidize AAI. Human and rat CYP1A are the major enzymes oxidizing AAI. Other CYPs such as CYP2C, 3A4, 2D6, 2E1, and 1B1, also form AAIa, but with much lower efficiency than CYP1A. Based on velocities of AAIa formation by examined CYPs and their expression levels in human and rat livers, here we determined the contributions of individual CYPs to AAI oxidation in these organs. Human CYP1A2 followed by CYP2C9, 3A4 and 1A1 were the major enzymes contributing to AAI oxidation in human liver, while CYP2C and 1A were most important in rat liver. We employed flexible in silico docking methods to explain the differences in AAI oxidation in the liver by human CYP1A1, 1A2, 2C9, and 3A4, the enzymes that all O-demethylate AAI, but with different effectiveness. We found that the binding orientations of the methoxy group of AAI in binding centers of the CYP enzymes and the energies of AAI binding to the CYP active sites dictate the efficiency of AAI oxidation. Our results indicate that utilization of experimental and theoretical methods is an appropriate study design to examine the CYP-catalyzed reaction mechanisms of AAI oxidation and contributions of human hepatic CYPs to this metabolism.

Zobrazit více v PubMed

PubMed DOI

PubMed

PubMed DOI

PubMed DOI

PubMed DOI

PubMed DOI PMC

International Agency for Research on Cancer (IARC) Environ. Health Criteria Monographs. Volume 100A World Health Organization; Geneva, Switzerland: 2012. A review of human CARCINOGENS: Pharmaceuticals.

PubMed DOI

PubMed DOI PMC

PubMed DOI

PubMed DOI PMC

PubMed DOI

PubMed DOI

PubMed DOI

PubMed DOI

PubMed

PubMed DOI

PubMed DOI

PubMed DOI

PubMed DOI

PubMed DOI

PubMed DOI

PubMed DOI

PubMed DOI PMC

PubMed DOI

PubMed DOI PMC

PubMed DOI

PubMed DOI PMC

PubMed DOI

PubMed DOI PMC

PubMed DOI

PubMed DOI

PubMed DOI

PubMed DOI PMC

PubMed DOI

PubMed

PubMed DOI

PubMed DOI

PubMed DOI

PubMed DOI

PubMed

Arlt V.M., Henderson C.J., Wolf C.R., Stiborova M., Phillips D.H. The Hepatic Reductase Null (HRN™) and Reductase Conditional Null (RCN) mouse models as suitable tools to study metabolism, toxicity and carcinogenicity of environmental pollutants. Toxicol. Res. 2015;4:548–562. doi: 10.1039/C4TX00116H. DOI

PubMed DOI

PubMed DOI

PubMed

PubMed

PubMed DOI PMC

PubMed DOI

PubMed DOI

PubMed DOI

PubMed DOI

PubMed DOI

PubMed DOI

PubMed DOI

PubMed

PubMed DOI

PubMed DOI

PubMed

PubMed DOI

PubMed DOI

PubMed DOI

PubMed DOI

PubMed

PubMed DOI

PubMed DOI

PubMed DOI PMC

PubMed DOI

PubMed DOI

PubMed DOI

PubMed

PubMed DOI

PubMed DOI

PubMed DOI

PubMed DOI

PubMed DOI

PubMed

PubMed

PubMed DOI

PubMed DOI

PubMed

PubMed DOI

PubMed DOI PMC

PubMed DOI

PubMed DOI

PubMed

PubMed

PubMed DOI

PubMed DOI PMC

PubMed DOI

PubMed DOI

Frisch M., Trucks G.W., Schlegel H.B., Robb M.A., Cheeseman J.R. Gaussian 03. Gaussian Inc.; Wallingford, CT, USA: 2003.

Nejnovějších 20 citací...

Zobrazit více v
Medvik | PubMed

Co-Exposure to Aristolochic Acids I and II Increases DNA Adduct Formation Responsible for Aristolochic Acid I-Mediated Carcinogenicity in Rats

. 2021 Sep 28 ; 22 (19) : . [epub] 20210928

Exposure to endocrine disruptors 17alpha-ethinylestradiol and estradiol influences cytochrome P450 1A1-mediated genotoxicity of benzo[a]pyrene and expression of this enzyme in rats

. 2018 May 01 ; 400-401 () : 48-56. [epub] 20180409

DNA Adducts Formed by Aristolochic Acid Are Unique Biomarkers of Exposure and Explain the Initiation Phase of Upper Urothelial Cancer

. 2017 Oct 14 ; 18 (10) : . [epub] 20171014

Comparison of the oxidation of carcinogenic aristolochic acid I and II by microsomal cytochromes P450 in vitro: experimental and theoretical approaches

. 2017 ; 148 (11) : 1971-1981. [epub] 20170726

Lipid molecules can induce an opening of membrane-facing tunnels in cytochrome P450 1A2

. 2016 Nov 09 ; 18 (44) : 30344-30356.

Balkan endemic nephropathy: an update on its aetiology

. 2016 Nov ; 90 (11) : 2595-2615. [epub] 20160819

NADPH- and NADH-dependent metabolism of and DNA adduct formation by benzo[a]pyrene catalyzed with rat hepatic microsomes and cytochrome P450 1A1

. 2016 ; 147 () : 847-855. [epub] 20160309

Induction of cytochromes P450 1A1 and 1A2 suppresses formation of DNA adducts by carcinogenic aristolochic acid I in rats in vivo

. 2016 Feb 17 ; 344-346 () : 7-18. [epub] 20160201

Active Site Mutations as a Suitable Tool Contributing to Explain a Mechanism of Aristolochic Acid I Nitroreduction by Cytochromes P450 1A1, 1A2 and 1B1

. 2016 Feb 05 ; 17 (2) : 213. [epub] 20160205

Najít záznam

Citační ukazatele

Nahrávání dat...

Možnosti archivace

Nahrávání dat...